SARTORIUS AG UNSP.ADR 1/5 (SRT4) - Cash Flow Conversion Efficiency
Based on the latest financial reports, SARTORIUS AG UNSP.ADR 1/5 (SRT4) has a cash flow conversion efficiency ratio of 0.049x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€188.90 Million ≈ $220.84 Million USD) by net assets (€3.89 Billion ≈ $4.55 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of SARTORIUS AG UNSP.ADR 1/5 to measure how much of total assets are equity-financed.
SARTORIUS AG UNSP.ADR 1/5 - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how SARTORIUS AG UNSP.ADR 1/5's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check SARTORIUS AG UNSP.ADR 1/5 earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
SARTORIUS AG UNSP.ADR 1/5 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SARTORIUS AG UNSP.ADR 1/5 ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PSP SWISS ADR 1/5/SF1050
F:P7S0
|
0.011x |
|
Ralliant Corporation Common Stock
NYSE:RAL
|
0.012x |
|
Hexcel Corporation
NYSE:HXL
|
0.100x |
|
Vornado Realty Trust
NYSE:VNO
|
0.005x |
|
Stockland
AU:SGP
|
-0.030x |
|
Ramsay Health Care Ltd
AU:RHC
|
0.062x |
|
VinFast Auto Ltd. Ordinary Shares
NASDAQ:VFS
|
0.134x |
|
Cirrus Logic Inc
NASDAQ:CRUS
|
0.071x |
Annual Cash Flow Conversion Efficiency for SARTORIUS AG UNSP.ADR 1/5 (2021–2025)
The table below shows the annual cash flow conversion efficiency of SARTORIUS AG UNSP.ADR 1/5 from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see SARTORIUS AG UNSP.ADR 1/5 (SRT4) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €3.87 Billion ≈ $4.52 Billion |
€837.00 Million ≈ $978.54 Million |
0.216x | -13.58% |
| 2024-12-31 | €3.90 Billion ≈ $4.56 Billion |
€976.20 Million ≈ $1.14 Billion |
0.250x | -19.08% |
| 2023-12-31 | €2.76 Billion ≈ $3.22 Billion |
€853.60 Million ≈ $997.95 Million |
0.309x | +12.09% |
| 2022-12-31 | €2.66 Billion ≈ $3.11 Billion |
€734.20 Million ≈ $858.36 Million |
0.276x | -45.60% |
| 2021-12-31 | €1.72 Billion ≈ $2.01 Billion |
€873.20 Million ≈ $1.02 Billion |
0.508x | -- |
About SARTORIUS AG UNSP.ADR 1/5
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management pro… Read more